These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1423332)

  • 1. Steroid antagonists as nuclear receptor blockers.
    Wakeling AE
    Cancer Surv; 1992; 14():71-85. PubMed ID: 1423332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular strategy to control tamoxifen resistant breast cancer.
    Jiang SY; Jordan VC
    Cancer Surv; 1992; 14():55-70. PubMed ID: 1423331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner.
    Ray S; Johnston R; Campbell DC; Nugent S; McDade SS; Waugh D; Panov KI
    Gene; 2013 Aug; 526(1):46-53. PubMed ID: 23608168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of antihormone action.
    Gronemeyer H; Benhamou B; Berry M; Bocquel MT; Gofflo D; Garcia T; Lerouge T; Metzger D; Meyer ME; Tora L
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):217-21. PubMed ID: 1562505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor and heterogeneous nuclear ribonucleoprotein K colocalize in the nucleoplasm and are modulated by bicalutamide and 4-hydroxy-tamoxifen in prostatic cancer cell lines.
    Barboro P; Repaci E; Ferrari N; Rubagotti A; Boccardo F; Balbi C
    Prostate; 2011 Sep; 71(13):1466-79. PubMed ID: 21321982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
    Arnold JT; Liu X; Allen JD; Le H; McFann KK; Blackman MR
    Prostate; 2007 Aug; 67(11):1152-62. PubMed ID: 17503469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ligand in oestrogen-receptor function.
    Parker MG; Fawell SE; Danielian P; Arbuckle N
    Biochem Soc Trans; 1991 Nov; 19(4):897-9. PubMed ID: 1794579
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists.
    Kraus WL; Katzenellenbogen BS
    Endocrinology; 1993 Jun; 132(6):2371-9. PubMed ID: 8504742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.
    Gielen SC; Burger CW; Kühne LC; Hanifi-Moghaddam P; Blok LJ
    J Soc Gynecol Investig; 2005 Oct; 12(7):e55-67. PubMed ID: 16202921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
    Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J
    Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological mechanism of action and development of anti-steroid hormones].
    Oh-ishi S
    Nihon Rinsho; 1994 Mar; 52(3):679-84. PubMed ID: 8164367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element.
    Ignar-Trowbridge DM; Teng CT; Ross KA; Parker MG; Korach KS; McLachlan JA
    Mol Endocrinol; 1993 Aug; 7(8):992-8. PubMed ID: 8232319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.
    Zhang X; Jeyakumar M; Petukhov S; Bagchi MK
    Mol Endocrinol; 1998 Apr; 12(4):513-24. PubMed ID: 9544987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations.
    van Agthoven T; van Agthoven TL; Dekker A; Foekens JA; Dorssers LC
    Mol Endocrinol; 1994 Nov; 8(11):1474-83. PubMed ID: 7533260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction and dissociation by ligands of estrogen receptor and Hsp90: the antiestrogen RU 58668 induces a protein synthesis-dependent clustering of the receptor in the cytoplasm.
    Devin-Leclerc J; Meng X; Delahaye F; Leclerc P; Baulieu EE; Catelli MG
    Mol Endocrinol; 1998 Jun; 12(6):842-54. PubMed ID: 9626660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.
    Havrilesky LJ; McMahon CP; Lobenhofer EK; Whitaker R; Marks JR; Berchuck A
    J Soc Gynecol Investig; 2001; 8(2):104-13. PubMed ID: 11336882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of steroid hormones and antihormones in cultured cells.
    Jung-Testas I; Baulieu EE
    Exp Clin Endocrinol; 1985 Dec; 86(2):151-64. PubMed ID: 2936615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.
    Liang Y; Hou M; Kallab AM; Barrett JT; El Etreby F; Schoenlein PV
    Int J Oncol; 2003 Aug; 23(2):369-80. PubMed ID: 12851686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.